Iquix Santen - Treatment for Bacterial Corneal Ulcers
Iquix contains levofloxacin, a potent fluoroquinolone active against a broad spectrum of Gram-positive and Gram-negative ocular pathogens. Iquix is indicated for the treatment of bacterial corneal ulcers.Posted: March 2004
Iquix (levofloxacin ophthalmic) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
